Scientists in the U.K. seem to have unearthed yet another benefit of exercise: It could make our bodies better at using up certain kinds of fat. In a new study out this week, researchers found that endurance athletes were much better at burning off saturated fat compared to sedentary people with type 2 diabetes—a…
At least 224 people have been injured after an iPhone app called t:connect drained the battery on its accompanying insulin pump, called t:slim X2, causing the pump to fail to deliver insulin. The FDA issued a Class I recall of the app on Wednesday, according to a press release, the most serious type of recall issued…
The UK has embarked on a first-of-its-kind initiative that will make the lives of many diabetics much easier. The country is set to provide artificial pancreas devices to tens of thousands of people living with type 1 diabetes. The recently approved devices should eliminate the need for patients to constantly measure…
Grace Cochran
Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with…
MIT scientists might be one step closer to making insulin injections a thing of the past. In a new study this week, they’ve shown that it’s possible to implant a medical device inside mice that produces its own supply of insulin for up to a month. More research will be needed before this technology would be widely…
A lab-made antibody could one day make organ transplants less of an ordeal, recent research suggests. In experiments with nonhuman primates, the antibody appeared to be safe and effective at preventing the rejection of transplanted kidneys and pancreatic cells. Scientists hope that this treatment could reduce or even…
On Thursday, Vermont Sen. Bernie Sanders and a gaggle of Democrats introduced a new bill that would cap insulin drug prices to just $20 per vial no matter which company is making it.
An Insulin drugmaker announced it is making its drug more affordable for some diabetics and is capping the out-of-pocket cost at $35 per month. Eli Lilly is making Insulin immediately available to seniors on Medicare. It’s welcome news to the many Americans who rely on insulin, as the cost of care has soared in recent…
